NEW YORK, June 2 /PRNewswire/ -- RWD Acquisition I LLC ("RWD")
announced today that the offering period to its previously announced tender
offer for up to 4,000,000 shares of common stock, par value $0.0001 per
share (the "Shares") of Pharmacyclics, Inc. (Nasdaq: PCYC)
("Pharmacyclics") expired at midnight, New York time, on May 30, 2008.
Based upon a preliminary tally by The Colbent Corporation, the depositary
for the offer, 1,758,060 Shares were tendered and approximately 224,621
additional Shares were guaranteed for delivery within three trading days,
for a preliminary total of 1,982,681 Shares (representing approximately
7.6% of all outstanding Shares). All tendered Shares were accepted for
payment pursuant to the terms of the offer. Payment for Shares accepted for
purchase is expected to be made promptly.

    After giving effect to the results of the offer and previous share
acquisitions, Robert W. Duggan, who is the sole member of RWD, may the
beneficial holder of up to 6,370,097 Shares, representing approximately
24.5% of all outstanding Shares. According to Pharmacyclics' most recent
Quarterly Report on Form 10-Q for the quarter ended March 31, 2008, filed
with the Securities and Exchange Commission on April 29, 2008, as of that
date, there were 25,994,490 Shares issued and outstanding, entitled to one
vote per Share.

    Questions should be directed to the offer information agent, Mackenzie
Partners, Inc., at 1-800-322-2885.

Link to this page: